Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection

Shoenfeld, 1989, The mosaic of autoimmunity, Immunol. Today, 10, 123, 10.1016/0167-5699(89)90245-4 Amital, 2006, Reshaping the mosaic of autoimmunity, Semin. Arthritis Rheum., 35, 341, 10.1016/j.semarthrit.2005.09.002 Fujinami, 2006, Molecular mimicry, bystander activation or viral persistence: infections and autoimmune disease, Clin. Microbiol. Rev., 19, 80, 10.1128/CMR.19.1.80-94.2006 Ercolini, 2009, The role of infections in autoimmune disease, Clin. Exp. Immunol., 155, 1, 10.1111/j.1365-2249.2008.03834.x Hussein, 2019, The role of viral infections in the development of autoimmune diseases, Crit Rev Microbiol 45, 394, 10.1080/1040841X.2019.1614904 Chang, 2021, Autoantibodies in moderate to critical cases of COVID 19, Clin Transl Sci, 14, 1625, 10.1111/cts.13036 Muratori, 2021, Antinuclear antibodies in COVID19, Clin Transl Sci, 14, 1627, 10.1111/cts.13026 Lerma, 2020, Prevalence of autoantibody response in acute coronavirus disease 2019 (COVID 19), J Transl Autoimmun, 3 100073, 1 Gagiannis, 2020 Shovman, 2005, Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies Lynch, 2022, Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test, Clin. Chem., 68, 702, 10.1093/clinchem/hvab283 Pascolini, 2021, COVID-19 and immunological dysfuncion: can autoantibodies be useful?, Clin Trans Sci, 14, 502, 10.1111/cts.12908 Liu, 2020, COVID-19 and autoimmune disease, Curr. Opin. Rheumatol., 33, 155, 10.1097/BOR.0000000000000776 Garcia-Beltran, 2021, COVID-19-neutralizing antibodies predict disease severity and survival, Cell, 184, 476, 10.1016/j.cell.2020.12.015 Shovman, 2005, Evaluation of the BioPlex™ 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies, Ann. N. Y. Acad. Sci., 1050, 380, 10.1196/annals.1313.120 Katz, 2020, Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana's healthy population, Sci. Rep., 10, 2814, 10.1038/s41598-020-59693-x Litwin, 2018, Anti-ENA antibody profiles in patients with hepatitis C virus infection, J. Clin. Lab. Anal., 32, 10.1002/jcla.22279 Yuan, 2022, Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases, Clin. Rheumatol., 41, 899, 10.1007/s10067-021-05946-7 Combe, 1989, Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue disease, Clin. Exp. Immunol., 75, 18 Alacon-Segovia, 1989, Comparison between three diagnostic criteria for mixed connective tissue disease. Study of 593 patients, J. Rheumatol., 16, 328 Zuo, 2020, Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19, Sci. Transl. Med., 12, 10.1126/scitranslmed.abd3876 Ahmed, 2021, COVID-19 and the clinical course of rheumatic manifestation, Clin. Rheumatol., 40, 2611, 10.1007/s10067-021-05691-x Dotan, 2021, The SARS-CoV2 as an instrumental trigger of autoimmunity, Autoimmun. Rev., 20, 4, 10.1016/j.autrev.2021.102792 Douvas, 1996, Neutralization of HIV Type I infectivity by serum antibodies from a subset of autoimmune patients with mixed connective tissue disease, AIDS Res. Hum. Retrovir., 12, 1509, 10.1089/aid.1996.12.1509 Koshy, 2018, Antinuclear antibodies in scrub typhus: transient occurrence during acute illness, J. Vector Borne Dis., 55, 52, 10.4103/0972-9062.234627 Sacchi, 2021, SARS-CoV-2 infection as a trigger of autoimmune response, Clin Transl Sci, 14, 898, 10.1111/cts.12953